This paper is in the following e-collection/theme issue:

Design and Usability of Medical Devices (156) Mobile Health (mhealth) (3614) HIV/AIDS/STI Prevention and Care (1078) Mobile Health (mhealth) (3614) AI Applications in Public Health (37) HIV/AIDS/STI Prevention and Care (1078) Harm Reduction Approaches (43) Design and Formative Evaluation of Mobile Apps (829) Usability of Apps and User Perceptions of mHealth (1231) Mobile Health (mhealth) (3614) HIV/AIDS/STI Prevention and Care (1078) Harm Reduction Approaches (43) Design and Formative Evaluation of Mobile Apps (829) Usability of Apps and User Perceptions of mHealth (1231) Mobile Health (mhealth) (3614) HIV/AIDS/STI Prevention and Care (1078) Harm Reduction Approaches (43) Usability of Apps and User Perceptions of mHealth (1231) Mobile Health (mhealth) (3614)

Published on in Vol 13 (2026)

This is a member publication of

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81111, first published .
Feasibility and Preferences to Adopt mHealth-Based Interventions for HIV Prevention Among High-Risk Groups: Cross-Sectional Study

Feasibility and Preferences to Adopt mHealth-Based Interventions for HIV Prevention Among High-Risk Groups: Cross-Sectional Study

Feasibility and Preferences to Adopt mHealth-Based Interventions for HIV Prevention Among High-Risk Groups: Cross-Sectional Study

Authors of this article:

Faizur Rehman1 Author Orcid Image ;   Muhammad Wasay Shahid1 Author Orcid Image ;   Mehran Riaz1 Author Orcid Image ;   Malik Muhammad Umair2 Author Orcid Image ;   Farah Azhar3 Author Orcid Image ;   Adeel Siddiqui4 Author Orcid Image ;   Ali Ahmed5 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics

Faizur Rehman   1 , PharmD ;   Muhammad Wasay Shahid   1 , PharmD ;   Mehran Riaz   1 , PharmD ;   Malik Muhammad Umair   2 , MBBS, MPH ;   Farah Azhar   3 , PharmD, PhD ;   Adeel Siddiqui   4 , PharmD, MPhil ;   Ali Ahmed   5 , PharmD, PhD

1 Department of Pharmacy Practice, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan

2 Common Management Unit, National Institute of Health, Islamabad, Pakistan

3 Department of Pharmaceutics, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan

4 Department of Pharmacy, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan

5 Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, La Jolla, CA, United States

Corresponding Author:

  • Ali Ahmed, PharmD, PhD
  • Division of Infectious Diseases and Global Public Health
  • School of Medicine, University of California, San Diego
  • La Jolla, CA 92093
  • United States
  • Phone: 1 619-953-9767
  • Email: aliahmed@health.ucsd.edu